Dan Grandér

9.5k total citations · 1 hit paper
125 papers, 6.5k citations indexed

About

Dan Grandér is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dan Grandér has authored 125 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 53 papers in Oncology and 30 papers in Immunology. Recurrent topics in Dan Grandér's work include Chronic Lymphocytic Leukemia Research (23 papers), Cytokine Signaling Pathways and Interactions (23 papers) and Cancer-related Molecular Pathways (19 papers). Dan Grandér is often cited by papers focused on Chronic Lymphocytic Leukemia Research (23 papers), Cytokine Signaling Pathways and Interactions (23 papers) and Cancer-related Molecular Pathways (19 papers). Dan Grandér collaborates with scholars based in Sweden, United States and United Kingdom. Dan Grandér's co-authors include Stefan Einhorn, Per Johnsson, Katja Pokrovskaja Tamm, Kevin V. Morris, Martin Corcoran, Olle Sangfelt, Theocharis Panaretakis, Leonard Lipovich, Mats Heyman and Sven Erickson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Dan Grandér

123 papers receiving 6.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolutionary conservation of long non-coding RNAs; sequence, structure, function

2013 536 citations Per Johnsson, Dan Grandér et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Dan Grandér	3.9k	1.9k	1.7k	1.4k	819	125	6.5k
Vundavalli V. Murty	4.4k 1.1×	1.3k 0.7×	1.9k 1.1×	939 0.7×	503 0.6×	109	7.2k
Domenico Delia	4.2k 1.1×	1.2k 0.7×	2.5k 1.5×	950 0.7×	379 0.5×	125	6.9k
Noboru Motoyama	5.1k 1.3×	1.1k 0.6×	1.8k 1.0×	1.8k 1.3×	617 0.8×	63	7.6k
Juan M. Zapata	4.0k 1.0×	1.2k 0.7×	1.4k 0.8×	1.8k 1.3×	445 0.5×	81	6.2k
Alexei Protopopov	5.6k 1.4×	2.1k 1.1×	1.4k 0.8×	744 0.5×	304 0.4×	88	8.0k
John Manis	6.2k 1.6×	979 0.5×	2.3k 1.3×	3.0k 2.1×	1.1k 1.3×	78	9.3k
Jason D. Weber	6.2k 1.6×	1.4k 0.8×	3.9k 2.2×	1.6k 1.1×	623 0.8×	78	8.9k
David T. Weaver	6.5k 1.7×	1.3k 0.7×	2.6k 1.5×	1.4k 1.0×	384 0.5×	150	9.0k
Pierre Dubus	5.3k 1.3×	1.2k 0.6×	4.0k 2.3×	1.1k 0.7×	645 0.8×	163	9.7k
Tsuneo Ikenoue	5.5k 1.4×	939 0.5×	1.8k 1.1×	1.3k 0.9×	692 0.8×	115	9.3k

Countries citing papers authored by Dan Grandér

Since Specialization

Citations

This map shows the geographic impact of Dan Grandér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Grandér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Grandér more than expected).

Fields of papers citing papers by Dan Grandér

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Grandér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Grandér. The network helps show where Dan Grandér may publish in the future.

Co-authorship network of co-authors of Dan Grandér

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Grandér. A scholar is included among the top collaborators of Dan Grandér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Grandér. Dan Grandér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Lisa L., Vivien Béziat, Vincent Yi Sheng Oei, et al.. (2017). Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells. Cancer Immunology Research. 5(8). 654–665. 61 indexed citations

Kolosenko, Iryna, Matheus Dyczynski, Jianping Liu, et al.. (2017). Identification of novel small molecules that inhibit STAT3-dependent transcription and function. PLoS ONE. 12(6). e0178844–e0178844. 18 indexed citations

Lohcharoenkal, Warangkana, Masako Harada, Jakob Lovén, et al.. (2016). MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. Journal of Investigative Dermatology. 136(12). 2485–2494. 32 indexed citations

Gatt, Moshe E., Kohichi Takada, Mala Mani, et al.. (2013). TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity. British Journal of Haematology. 162(2). 210–220. 24 indexed citations

Thulin, Petra, Tianling Wei, L.K. Cheung, et al.. (2013). MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response. International Journal of Molecular Medicine. 31(5). 1003–1010. 73 indexed citations

Kharaziha, Pedram, Hendrik De Raeve, Qiao Li, et al.. (2012). Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro , Ex Vivo , and In Vivo in the 5T33MM Mouse Model. Cancer Research. 72(20). 5348–5362. 42 indexed citations

Malyukova, Alena, Takeaki Dohda, Natalie von der Lehr, et al.. (2007). The Tumor Suppressor Gene hCDC4 Is Frequently Mutated in Human T-Cell Acute Lymphoblastic Leukemia with Functional Consequences for Notch Signaling. Cancer Research. 67(12). 5611–5616. 148 indexed citations

Dohda, Takeaki, Alena Maljukova, Lei Liu, et al.. (2007). Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Experimental Cell Research. 313(14). 3141–3152. 95 indexed citations

Lerner, Mikael, Martin Corcoran, Diana Cepeda, et al.. (2007). The RBCC GeneRFP2(Leu5) Encodes a Novel Transmembrane E3 Ubiquitin Ligase Involved in ERAD. Molecular Biology of the Cell. 18(5). 1670–1682. 95 indexed citations

10.

Panaretakis, Theocharis, et al.. (2007). Interferon α Induces Nucleus-independent Apoptosis by Activating Extracellular Signal-regulated Kinase 1/2 and c-Jun NH₂-Terminal Kinase Downstream of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin. Molecular Biology of the Cell. 19(1). 41–50. 41 indexed citations

11.

Thyrell, Lena, Olle Sangfelt, Boris Zhivotovsky, et al.. (2005). The HPV-16 E7 Oncogene Sensitizes Malignant Cells to IFN-α-Induced Apoptosis. Journal of Interferon & Cytokine Research. 25(2). 63–72. 8 indexed citations

12.

Tamm, Katja Pokrovskaja, Theocharis Panaretakis, & Dan Grandér. (2005). Alternative Signaling Pathways Regulating Type I Interferon-Induced Apoptosis. Journal of Interferon & Cytokine Research. 25(12). 799–810. 40 indexed citations

13.

Panaretakis, Theocharis, Edward Laane, Katja Pokrovskaja Tamm, et al.. (2005). Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase Cδ, and c-Jun NH₂-terminal Kinase to Induce Apoptosis. Molecular Biology of the Cell. 16(8). 3821–3831. 92 indexed citations

14.

Kuchinskaya, Ekaterina, Mats Heyman, Dan Grandér, et al.. (2005). Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. European Journal Of Haematology. 74(6). 466–480. 18 indexed citations

15.

Thyrell, Lena, Velmurugesan Arulampalam, Theocharis Panaretakis, et al.. (2004). Interferon α-induced Apoptosis in Tumor Cells Is Mediated through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling Pathway. Journal of Biological Chemistry. 279(23). 24152–24162. 98 indexed citations

16.

Gustafsson, Göran, Stanislaw Garwicz, Dan Grandér, et al.. (2002). Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia. 16(10). 2037–2045. 26 indexed citations

17.

Erickson, Sven, Sampsa Matikainen, Lena Thyrell, et al.. (2002). Interferon‐alpha inhibits Stat5 DNA‐binding in IL‐2 stimulated primary T‐lymphocytes. European Journal of Biochemistry. 269(1). 29–37. 17 indexed citations

18.

Grandér, Dan. (2000). How Does Interferon-Alpha Exert Its Antitumour Activity in Multiple Myeloma?. Acta Oncologica. 39(7). 801–805. 16 indexed citations

19.

Grandér, Dan, et al.. (1996). Chromosome 13q14 deletions in lymphoid malignancies. Data Archiving and Networked Services (DANS). 1 indexed citations

20.

Liu, Yie, Mats Heyman, Dan Grandér, et al.. (1994). Multiple genetic events involving rbi gene deletion and amplification of chromosome 21 in a case of acute lymphocytic leukemia. Genes Chromosomes and Cancer. 9(1). 72–75. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact